Master your fundamental research. Join 78,618 investors who trust our platform and content.
Save 54+ hours of fundamental research with free access to Stock Card.
We only ask your name and email address.
We are looking at Alexion Pharmaceuticals (ALXN) today.
Why Alexion Pharmaceuticals (ALXN) shares fell more than 3% today?
Shares of Alexion Pharmaceuticals lost more than 3% on Wednesday. The SEC is fining the company for bribing foreign government officials to receive favorable treatment. The company's subsidiaries from 2010 to 2015 in Turkey and Russia from 2011 to 2015 bribed officials and maintained false records of such payments. The fine is adding up to a bit more than $20 million, but investors hate such dealings with the SEC, as they should. And, the stock is paying the price.
The company is still a very well-managed, cash-rich pharmaceutical that develops treatment for rare diseases such as multiple sclerosis (M.S.). Its SOLIRIS® (ECULIZUMAB) is a leading drug in the U.S. Assuming that this bribery case doesn't snowball to a bigger fraud, the stock is hovering in an undervalued range that may be worth adding to your watchlist. Check out the company's Stock Card to see the evidence of its strong operations.
We are looking at Livongo (LVGO) today.
Why Livongo (LVGO) stock jumped today?
Shares of Livongo Health were up more than 20% on Tuesday. The company announced a preliminary second-quarter report, and revenue growth is exceeding everyone's expectations.
If you don't know the company, this might be a good time to add it to your watchlist. The company is a technology platform provider for the detection and prevention of diabetes in the United States. The company's solution expands into other medical conditions, such as weight management. Livongo is not profitable but has more than a 70% gross margin. With no debt on its balance sheet, it continues to fund its growth without worrying about cash. The COVID-19 pandemic has helped the company grow even faster ad more employers are looking for digital ways to help their employees manage their health. Check out the company's Stock Card to have an eye on it:
We are looking at Dominion Energy (D) today.
Why Dominion Energy (D) stock fell today?
We are looking at Workhorse Group (WKHS) today.
Why Workhorse Group (WKHS) stock jumped today?
Shares of Workhorse Group (WKHS) were up more than 18% on Wednesday. It seems that the company is getting a nod of approval from financial analysts and investors alike. As an example, BTIG analyst Gregory Lewis almost doubled his price target for the stock. It also didn't hurt for the stock to join the Russell 3000® index, which brings more attention, media, and analysts coverage.
So, what's all the fuss about?
Founded in 2007, the company already has nearly 400 vehicles on the road. The company has a partnership with USPS to manufacture electric delivery vehicles for the United States Postal Service. The company is already delivering its product to customers such as UPS. More interesting is the company's last-mile delivery vehicles that are equipped with delivery drones. The last-mile delivery market is an $18 billion market opportunity, and Workhorse has a head start. What has caught investors' attention is the recent partnership with Lordstown Motors, who plans to license and manufacture electric pickup trucks utilizing the Workhorse's W-15 Technology.
The bothersome aspect of the company's operations is its balance sheet. It has a high debt-to-equity ratio, and its earnings are not enough to cover its debt obligations. Despite the steady progress and rapid revenue growth the company is making, this is a risky bet for investors who are in love with the electric truck market. Check out the company's Stock Card before you decide what to do with it. Here you go ...
One of the best ways to invest in risky stocks such as WKHS is to go slow and small and avoid taking too much risk. Here are our top three brokerages that allow you to invest with a small amount of money:
We are looking at Boeing (BA) today.
Why Boeing (BA) stock fell today?
The news is that airlines have gradually started to cancel their 737 Max orders, which means the company will have a tough time moving its already 400 manufactured planes. This corporate crisis is much deeper and lingering longer than most investors had previously expected.
Moreover, a 52-page report is expected to get released on Wednesday by the U.S. Department of Transportation's Office of Inspector General (IG) to outline what has gone wrong during the certification process of 737 Max jets that ended up causing two fatal crashes.
Boeing's story is a perfect reminder to investors that corporate crises last much longer than we all expect. There is no rush to buy the dip. True dips are extremely painful. True dips are hard and agonizing, and they typically take longer than expected to recover. This means to generate an outsized return from a stock dip, and you need to be extremely patient. Visit Boeing's Stock Card to review the 737 Max's impact on the company in more detail.
Investing in companies such as Boeing takes patience. If you choose to invest in it to benefit from its lower historical price, you need to have a long-term horizon as part of something like a retirement account with decades of waiting time. Personal Capital is an excellent platform we came across to manage your long term goals. Check it out: